These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25199968)

  • 21. The Efficacy and Safety of Intravenous Colistin Plus Aerosolized Colistin Versus Intravenous Colistin Alone in Critically Ill Trauma Patients With Multi-Drug Resistant Gram-Negative Bacilli Infection.
    Maan L; Anand N; Yadav G; Mishra M; Gupta MK
    Cureus; 2023 Nov; 15(11):e49314. PubMed ID: 38143689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study.
    Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME
    Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial.
    Cisneros JM; Rosso-Fernández CM; Roca-Oporto C; De Pascale G; Jiménez-Jorge S; Fernández-Hinojosa E; Matthaiou DK; Ramírez P; Díaz-Miguel RO; Estella A; Antonelli M; Dimopoulos G; Garnacho-Montero J;
    Crit Care; 2019 Nov; 23(1):383. PubMed ID: 31779711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin-meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae.
    Abdelsalam MFA; Abdalla MS; El-Abhar HSE
    J Glob Antimicrob Resist; 2018 Dec; 15():127-135. PubMed ID: 30010061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized antibiotics for ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis.
    Xu F; He LL; Che LQ; Li W; Ying SM; Chen ZH; Shen HH
    Crit Care; 2018 Nov; 22(1):301. PubMed ID: 30442203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
    J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
    Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
    J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
    Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
    BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of aerosolized colistin in the treatment of ventilator-associated pneumonia: a systematic review and metaanalysis.
    Valachis A; Samonis G; Kofteridis DP
    Crit Care Med; 2015 Mar; 43(3):527-33. PubMed ID: 25493971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the efficacy and safety of colistin for the treatment of ventilator-associated pneumonia? A systematic review and meta-regression.
    Florescu DF; Qiu F; McCartan MA; Mindru C; Fey PD; Kalil AC
    Clin Infect Dis; 2012 Mar; 54(5):670-80. PubMed ID: 22322268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
    Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.
    Bharathi KS; Bhat A; Pruthi G; Simha PP
    Ann Card Anaesth; 2022; 25(4):435-440. PubMed ID: 36254907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis.
    Chien HT; Lin YC; Sheu CC; Hsieh KP; Chang JS
    Int J Antimicrob Agents; 2020 Mar; 55(3):105889. PubMed ID: 31923573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
    Ghannam DE; Rodriguez GH; Raad II; Safdar A
    Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant Gram-negative infections: the use of colistin.
    Michalopoulos AS; Karatza DC
    Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1009-17. PubMed ID: 20818945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous combined with aerosolised polymyxins vs intravenous polymyxins monotherapy for ventilator-associated pneumonia: A systematic review and meta-analysis.
    Tong R; Zou X; Shi X; Zhang X; Li X; Liu S; Duan X; Han B; Wang H; Zhang R; Sun L; Kong Y; Zhang F; Ma M; Ding X; Sun T
    Int J Antimicrob Agents; 2024 Dec; 64(6):107357. PubMed ID: 39389385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.